Long-term retention in Office Based Opioid Treatment with buprenorphine.

  title={Long-term retention in Office Based Opioid Treatment with buprenorphine.},
  author={Zoe M Weinstein and Hyunjoong W Kim and Debbie M. Cheng and Emily Kate Quinn and David Hui and Colleen T Labelle and Mari-lynn Drainoni and Sara S. Bachman and Jeffrey H Samet},
  journal={Journal of substance abuse treatment},
BACKGROUND Guidelines recommend long-term treatment for opioid use disorder with buprenorphine; however, little is known about patients in long-term treatment. The aim of this study is to examine the prevalence and patient characteristics of long-term treatment retention (≥1year) in an Office Based Opioid Treatment (OBOT) program with buprenorphine. METHODS This is a retrospective cohort study of adults on buprenorphine from January 2002 to February 2014 in a large urban safety-net primary… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 19 times over the past 90 days. VIEW TWEETS